Estee Lauder Companies, Inc DossierEstee Lauder Companies, Inc generated $14.326 billion in net sales and reported an operating loss of $785 million for the fiscal year ended June 30, 2025, primarily influenced by challenges within the Asia travel retail channel and significant impairment charges. The company recorded a net loss attributable to Estee Lauder Companies, Inc of $1.133 billion for the twelve-month period. Financial Highlights* Net Sales: $14.326 billion * Net Loss Attributable to Estee Lauder Companies, Inc: $1.133 billion * Diluted Net Loss Per Common Share: $3.15 * Gross Margin: 74.0% * Net Cash Flows Provided by Operating Activities: $1.272 billion * Skin Care Segment Net Sales: $6.962 billion * Makeup Segment Net Sales: $4.205 billion * Fragrance Segment Net Sales: $2.491 billion Estee Lauder Companies, Inc is navigating a complex operating environment characterized by persistent softness in the Asia travel retail sector and shifting demand in key prestige beauty markets. The fiscal 2025 performance... Sign in / Sign up to learn more about Estee Lauder Companies, Inc Continue your research by chatting with our AI financial analyst about Estee Lauder Companies, Inc. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings. Start your analysis with these investor-focused questions: - Given that Estee Lauder Companies, Inc. experienced an 8% revenue decline but a 230 basis point expansion in gross margin in FY2025, what specific elements of the Profit Recovery and Growth Plan are most critical to translating these gross margin gains into positive operating income and net earnings?
- In FY2025, the Skin Care segment of Estee Lauder Companies, Inc. declined by 12%, while Fragrance sales were flat, supported by growth in brands like Le Labo. How should the company strategically reallocate its R&D and marketing investments across its brand portfolio to revitalize core skin care and makeup while capitalizing on the relative strength of its fragrance division?
- Estee Lauder Companies, Inc. recorded significant asset impairment charges of $1.286 billion in FY2025 for brands like Dr.Jart+ and TOM FORD. What do these impairments indicate about the company's past acquisition strategy, and what financial metrics should be scrutinized to evaluate the future performance and integration of its acquired brands?
- With the Travel Retail channel's contribution to sales for Estee Lauder Companies, Inc. falling to approximately 15% in FY2025 amidst a strong double-digit decline, what are the key financial and strategic implications of this reduced dependency, and how does it alter the company's growth prospects in different geographic regions?
- Considering the recent controversies for Estee Lauder Companies, Inc., including supply chain scrutiny and litigation settlements, how might these ESG and governance factors impact brand equity and the company's ability to attract and retain consumers, particularly when compared to competitors with stronger ESG profiles?
|
